Lexology July 31, 2020
On July 24, 2020, President Trump announced four Executive Orders (“Executive Orders”) characterized as focusing on lowering drug prices via various mechanisms. These Executive Orders, described in more detail below, include: (1) Executive Order on Access to Affordable Life-saving Medications; (2) Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen; (3) Executive Order on Increasing Drug Importation to Lower Prices for American Patients; and (4) a proposed Executive Order that would require Medicare to pay the lowest price for Part B drugs among other advanced nations. If fully implemented, the Executive Orders would no doubt have wide-ranging and significant impacts on various health care industry stakeholders including hospitals, pharmacies, physician offices, drug manufacturers and pharmacy benefit managers...
Today's Sponsors
Today's Sponsor